Skip to main content
. 2019 Nov 14;14(11):e0224226. doi: 10.1371/journal.pone.0224226

Table 3. Anticipated third-line patients under different scenarios.

2019 2020 2021 2022 2023
Anticipated total third-line patients with 90% treatment coverage and 90% routing viral load testing 442 471 501 534 572
Patients on third-line treatment currently forecasted 218 229 242 257 275
Difference between current forecast and anticipated total with partial 90-90-90 achievement 224 242 259 277 297